• Subscribe
    • Sign up for updates about the journal.
  • Sign in
  • Register
Exploration of Neuroprotective Therapy
  • About
    • About the Journal
    • Editorial Board
    • Editorial Policies
    • Newsletter
    • Contact Us
  • Articles
    • Current Issue
    • Archives
  • Special Issue
    • All Special Issues
    • Guest Editor Guidelines
  • For Authors
    • Author Instructions
    • Editorial Process
    • Article Processing Charge
    • Submit a Manuscript
  • For Reviewers
    • Peer Review Guidelines
    • Reviewer Acknowledgment
    • To Be a Reviewer
  • Focus
  • Home
  • Exploration of Neuroprotective Therapy
  • Focus
  • Focus

    Emerging Indications for Botulinum Toxin Treatment

    Prof. Lucio Marinelli
    Page View
    1292
    Jul. 14, 2023

    Neuroprotective and Neurorestorative Strategies: from Bench-to-Bedside

    Prof. Antonio Ibarra
    Page View
    1143
    Jul. 13, 2023
    • Submit a Manuscript
    • Aims and Scope
    • Editorial Board
    • Author Instructions
    • Exploration of Neuroprotective Therapy
    • eISSN 2769-6510
    • entjournal@explorationpub.com
    • About the Journal
    • Author Instructions
    • Editorial Board
    • Editorial Policies
    • Editorial Process
    • Follow the Journal
    • JOURNALS
    • Exploration of Medicine
    • Exploration of Targeted Anti-tumor Therapy
    • Exploration of Immunology
    • Exploration of Neuroprotective Therapy
    • Exploration of Neuroscience
    • Exploration of Digestive Diseases
    • Exploration of Musculoskeletal Diseases
    • Exploration of Drug Science
    • Exploration of Asthma & Allergy
    • Exploration of Foods and Foodomics
    • Exploration of Digital Health Technologies
    • Exploration of Cardiology
    • Exploration of BioMat-X
    • Exploration of Endocrine and Metabolic Diseases
    • ABOUT
    • Company Information
    • Open Access
    • Editorial Policies
    • Peer Review Policy
    • Contact Us
    • FOLLOW
    • Terms of Service Privacy Cookies
Copyright © 2024 Open Exploration Publishing Inc.